DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts (Q54097939)
scientific article
Language:
(P31) (Q13442814)
(P304) 1021-1030
(P407) (Q1860)
(P433) 6
(P478) 10
(P577) Thursday, April 1, 1999
(P921) (Q64148587)
(Q18555025)
(P1433) (Q15757580)
(P1476) "DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts" (language: en)
(P2093) O N Koç
J S Reese
B M Davis
L Liu
K J Majczenko
S L Gerson
other details
description scientific article

External Links